Apple and the US FDA discuss the medical application of smart watch iWatch

A report last Friday showed that Apple executives met with the US Food and Drug Administration (FDA) Director Margaret A. Hamburg and others in December last year to discuss mobile medical applications, which may confirm The rumored iWatch for health, fitness and medical care . At present, the details of Apple's conversation with the FDA director are still unknown.

However, according to the FDA's public calendar list, Apple attended the meeting with senior vice president of operations Jeff Williams, vice president of software and technology Bud Tribble, Michael O'Reilly and government attorney Tim Powderly. A few days ago, it was reported that O'Reilly had joined Apple last year, but the position is still unclear. Prior to joining Apple, Michael O'Reilly was the former Chief Medical Officer and Executive Vice President of Medical Affairs at Masimo Corporation. In addition, he was an adjunct associate professor of anesthesiology at the University of Michigan and a professor of anesthesia and perioperative care at the University of California, Irvine.

The FDA is represented by Jeff Shuren of the Center for Equipment and Radiation Health and Bakul Patel, who advocates patient safety. Patel is the author of the FAD Mobile Medical Application Guidelines. It has been speculated that Apple may want to negotiate with the FDA to remove the regulatory barriers to the release of medical applications or devices. Michael O'Reilly's participation in this meeting is very interesting, which means that the topic of the meeting may be related to the pulse rate. In addition, O'Reilly may have become the executive of Apple's iWatch team.

Roller Hook Tomato Plant Support

Roller Hook Tomato Plant Support,Tomato Trellis-trellising,Greenhouse Tomato Plant,Accessory Trellising Roller Hook

JIANGSU SKYPLAN GREENHOUSE TECHNOLOGY CO.,LTD , https://www.skyplantgreenhouse.com

Posted on